Supplementary Data from First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors
作者
Tae Won Kim,Howard A. Burris,Maria José De Miguel,Michael J. Pishvaian,Yung‐Jue Bang,Michael S. Gordon,Ahmad Hussein Awada,D. Ross Camidge,Frank Stephen Hodi,Grant A. McArthur,Wilson H. Miller,Andrès M.R. Cervantes,Laura Q.M. Chow,Alexander M. Lesokhin,Annemie Rutten,Mario Sznol,Deepali Rishipathak,Shang‐Chiung Chen,Eric Gary Stefanich,Tony Pourmohamad